Literature DB >> 21062900

A genome-wide RNAi screen identifies multiple RSK-dependent regulators of cell migration.

Gromoslaw A Smolen1, Jianmin Zhang, Matthew J Zubrowski, Elena J Edelman, Biao Luo, Min Yu, Lydia W Ng, Cally M Scherber, Benjamin J Schott, Sridhar Ramaswamy, Daniel Irimia, David E Root, Daniel A Haber.   

Abstract

To define the functional pathways regulating epithelial cell migration, we performed a genome-wide RNAi screen using 55,000 pooled lentiviral shRNAs targeting ∼11,000 genes, selecting for transduced cells with increased motility. A stringent validation protocol generated a set of 31 genes representing diverse pathways whose knockdown dramatically enhances cellular migration. Some of these pathways share features of epithelial-to-mesenchymal transition (EMT), and together they implicate key regulators of transcription, cellular signaling, and metabolism, as well as novel modulators of cellular trafficking, such as DLG5. In delineating downstream pathways mediating these migration phenotypes, we observed universal activation of ERKs and a profound dependence on their RSK effectors. Pharmacological inhibition of RSK dramatically suppresses epithelial cell migration induced by knockdown of all 31 genes, suggesting that convergence of diverse migratory pathways on this kinase may provide a therapeutic opportunity in disorders of cell migration, including cancer metastasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21062900      PMCID: PMC2994039          DOI: 10.1101/gad.1989110

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  46 in total

1.  The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression.

Authors:  A Cano; M A Pérez-Moreno; I Rodrigo; A Locascio; M J Blanco; M G del Barrio; F Portillo; M A Nieto
Journal:  Nat Cell Biol       Date:  2000-02       Impact factor: 28.824

2.  Identification of the first specific inhibitor of p90 ribosomal S6 kinase (RSK) reveals an unexpected role for RSK in cancer cell proliferation.

Authors:  Jeffrey A Smith; Celeste E Poteet-Smith; Yaming Xu; Timothy M Errington; Sidney M Hecht; Deborah A Lannigan
Journal:  Cancer Res       Date:  2005-02-01       Impact factor: 12.701

3.  An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival.

Authors:  Lance D Miller; Johanna Smeds; Joshy George; Vinsensius B Vega; Liza Vergara; Alexander Ploner; Yudi Pawitan; Per Hall; Sigrid Klaar; Edison T Liu; Jonas Bergh
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-02       Impact factor: 11.205

4.  Proteomic analysis of mammalian oligosaccharyltransferase reveals multiple subcomplexes that contain Sec61, TRAP, and two potential new subunits.

Authors:  Toru Shibatani; Larry L David; Ashley L McCormack; Klaus Frueh; William R Skach
Journal:  Biochemistry       Date:  2005-04-26       Impact factor: 3.162

5.  The serine/threonine protein kinase, p90 ribosomal S6 kinase, is an important regulator of prostate cancer cell proliferation.

Authors:  D E Clark; T M Errington; J A Smith; H F Frierson; M J Weber; D A Lannigan
Journal:  Cancer Res       Date:  2005-04-15       Impact factor: 12.701

6.  Down-regulation of RAB6KIFL/KIF20A, a kinesin involved with membrane trafficking of discs large homologue 5, can attenuate growth of pancreatic cancer cell.

Authors:  Keisuke Taniuchi; Hidewaki Nakagawa; Toru Nakamura; Hidetoshi Eguchi; Hiroaki Ohigashi; Osamu Ishikawa; Toyomasa Katagiri; Yusuke Nakamura
Journal:  Cancer Res       Date:  2005-01-01       Impact factor: 12.701

7.  p90 ribosomal S6 kinase 2 promotes invasion and metastasis of human head and neck squamous cell carcinoma cells.

Authors:  Sumin Kang; Shannon Elf; Katherine Lythgoe; Taro Hitosugi; Jack Taunton; Wei Zhou; Li Xiong; Dongsheng Wang; Susan Muller; Songqing Fan; Shi-Yong Sun; Adam I Marcus; Ting-Lei Gu; Roberto D Polakiewicz; Zhuo Georgia Chen; Fadlo R Khuri; Dong M Shin; Jing Chen
Journal:  J Clin Invest       Date:  2010-03-15       Impact factor: 14.808

Review 8.  MRP2 and 3 in health and disease.

Authors:  P Borst; N Zelcer; K van de Wetering
Journal:  Cancer Lett       Date:  2006-01-04       Impact factor: 8.679

9.  Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.

Authors:  Christos Sotiriou; Pratyaksha Wirapati; Sherene Loi; Adrian Harris; Steve Fox; Johanna Smeds; Hans Nordgren; Pierre Farmer; Viviane Praz; Benjamin Haibe-Kains; Christine Desmedt; Denis Larsimont; Fatima Cardoso; Hans Peterse; Dimitry Nuyten; Marc Buyse; Marc J Van de Vijver; Jonas Bergh; Martine Piccart; Mauro Delorenzi
Journal:  J Natl Cancer Inst       Date:  2006-02-15       Impact factor: 13.506

10.  p90Rsk is not involved in cytostatic factor arrest in mouse oocytes.

Authors:  Julien Dumont; Muriel Umbhauer; Pascale Rassinier; André Hanauer; Marie-Hélène Verlhac
Journal:  J Cell Biol       Date:  2005-04-18       Impact factor: 10.539

View more
  44 in total

Review 1.  Targeting protein kinases with selective and semipromiscuous covalent inhibitors.

Authors:  Rand M Miller; Jack Taunton
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

Review 2.  A primer on using pooled shRNA libraries for functional genomic screens.

Authors:  Guang Hu; Ji Luo
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2012-02       Impact factor: 3.848

3.  Cell migration in confined environments.

Authors:  Daniel Irimia
Journal:  Methods Cell Biol       Date:  2014       Impact factor: 1.441

4.  Regioselective Synthesis of a C-4'' Carbamate,C-6'' n-Pr Substituted Cyclitol Analogue of SL0101.

Authors:  Yu Li; Zachary M Sandusky; Rajender Vemula; Qi Zhang; Bulan Wu; Shinji Fukuda; Mingzong Li; Deborah A Lannigan; George A O'Doherty
Journal:  Org Lett       Date:  2020-02-03       Impact factor: 6.005

5.  Repositioning "old" drugs for new causes: identifying new inhibitors of prostate cancer cell migration and invasion.

Authors:  Esha T Shah; Akanksha Upadhyaya; Lisa K Philp; Tiffany Tang; Dubravka Skalamera; Jennifer Gunter; Colleen C Nelson; Elizabeth D Williams; Brett G Hollier
Journal:  Clin Exp Metastasis       Date:  2016-03-01       Impact factor: 5.150

Review 6.  Towards systematic functional characterization of cancer genomes.

Authors:  Jesse S Boehm; William C Hahn
Journal:  Nat Rev Genet       Date:  2011-06-17       Impact factor: 53.242

Review 7.  MSP-RON signalling in cancer: pathogenesis and therapeutic potential.

Authors:  Hang-Ping Yao; Yong-Qing Zhou; Ruiwen Zhang; Ming-Hai Wang
Journal:  Nat Rev Cancer       Date:  2013-07       Impact factor: 60.716

Review 8.  RSK isoforms in cancer cell invasion and metastasis.

Authors:  Florian J Sulzmaier; Joe W Ramos
Journal:  Cancer Res       Date:  2013-10-04       Impact factor: 12.701

9.  Development of a RSK Inhibitor as a Novel Therapy for Triple-Negative Breast Cancer.

Authors:  Katarzyna A Ludwik; J Preston Campbell; Mingzong Li; Yu Li; Zachary M Sandusky; Lejla Pasic; Miranda E Sowder; David R Brenin; Jennifer A Pietenpol; George A O'Doherty; Deborah A Lannigan
Journal:  Mol Cancer Ther       Date:  2016-08-15       Impact factor: 6.261

10.  TRAP1-dependent regulation of p70S6K is involved in the attenuation of protein synthesis and cell migration: relevance in human colorectal tumors.

Authors:  Danilo Swann Matassa; Ilenia Agliarulo; Maria Rosaria Amoroso; Francesca Maddalena; Leandra Sepe; Maria Carla Ferrari; Vinay Sagar; Silvia D'Amico; Fabrizio Loreni; Giovanni Paolella; Matteo Landriscina; Franca Esposito
Journal:  Mol Oncol       Date:  2014-06-13       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.